1. Home
  2. PML vs MGTX Comparison

PML vs MGTX Comparison

Compare PML & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PML
  • MGTX
  • Stock Information
  • Founded
  • PML 2002
  • MGTX 2015
  • Country
  • PML United States
  • MGTX United States
  • Employees
  • PML N/A
  • MGTX N/A
  • Industry
  • PML Investment Managers
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PML Finance
  • MGTX Health Care
  • Exchange
  • PML Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • PML 570.5M
  • MGTX 570.5M
  • IPO Year
  • PML N/A
  • MGTX N/A
  • Fundamental
  • Price
  • PML $8.05
  • MGTX $7.33
  • Analyst Decision
  • PML
  • MGTX Strong Buy
  • Analyst Count
  • PML 0
  • MGTX 2
  • Target Price
  • PML N/A
  • MGTX $24.50
  • AVG Volume (30 Days)
  • PML 188.0K
  • MGTX 770.2K
  • Earning Date
  • PML 01-01-0001
  • MGTX 03-13-2025
  • Dividend Yield
  • PML 5.65%
  • MGTX N/A
  • EPS Growth
  • PML N/A
  • MGTX N/A
  • EPS
  • PML N/A
  • MGTX N/A
  • Revenue
  • PML N/A
  • MGTX $33,279,000.00
  • Revenue This Year
  • PML N/A
  • MGTX $512.49
  • Revenue Next Year
  • PML N/A
  • MGTX $2.91
  • P/E Ratio
  • PML N/A
  • MGTX N/A
  • Revenue Growth
  • PML N/A
  • MGTX 137.42
  • 52 Week Low
  • PML $6.92
  • MGTX $3.85
  • 52 Week High
  • PML $9.46
  • MGTX $8.75
  • Technical
  • Relative Strength Index (RSI)
  • PML 30.76
  • MGTX 52.33
  • Support Level
  • PML $8.01
  • MGTX $7.13
  • Resistance Level
  • PML $8.21
  • MGTX $7.95
  • Average True Range (ATR)
  • PML 0.09
  • MGTX 0.50
  • MACD
  • PML -0.02
  • MGTX -0.02
  • Stochastic Oscillator
  • PML 9.30
  • MGTX 52.35

About PML Pimco Municipal Income Fund II of Beneficial Interest

PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: